Format

Send to

Choose Destination
Front Immunol. 2014 Feb 10;5:43. doi: 10.3389/fimmu.2014.00043. eCollection 2014.

Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease.

Author information

1
Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi," Milan , Italy.

Abstract

Induction of the adaptive immune system is evaluated mostly by assessment of serum antibody titers and T lymphocyte responses in peripheral blood, although T and B cell activation occurs in lymphoid tissues. In recent years, the release of microRNAs (miRNAs) in the extra-cellular environment has been exploited to assess cell functions at distance via measurement of serum miRNAs. Activated lymphocytes release a large amount of nano-sized vesicles (exosomes), containing miRNA, however there are insufficient data to determine whether this phenomenon is reflected in modulation of serum miRNAs. Interestingly, miRNA signatures of CD4(+) T cell-derived exosomes are substantially different from intracellular miRNA signatures of the same cells. We have recently identified serum circulating miR-150 as a sensor of general lymphocyte activation and we strongly believe that miRNAs differentially released by specific CD4(+) effector T cell subsets (Th1, Th2, Th17, and Treg) may serve as serum biomarkers of their elicitation in lymphoid tissues but also in damaged tissues, potentially providing clinically relevant information about the nature of immune responses in health and disease.

KEYWORDS:

T lymphocytes; circulating microRNAs; exosomes; vaccination

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center